表紙:臨床化学分析装置の世界市場 - 2023年~2030年
市場調査レポート
商品コード
1374781

臨床化学分析装置の世界市場 - 2023年~2030年

Global Clinical Chemistry Analyzers Market -2023-2030

出版日: | 発行: DataM Intelligence | ページ情報: 英文 187 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.94円
臨床化学分析装置の世界市場 - 2023年~2030年
出版日: 2023年11月01日
発行: DataM Intelligence
ページ情報: 英文 187 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

概要

世界の臨床化学分析装置市場は、そのダイナミクスに影響を与える様々な要因によって、長年にわたって大きな成長と変貌を遂げてきました。臨床化学分析装置は、自動化された医療検査機器の重要な部分です。これらの装置は、血液や尿のような生物学的サンプルの流体サンプルの組成を検査し、特性を決定します。これには高度な化学的手法や光学的手法が用いられます。

特に新興経済諸国では、政府による斬新な製品の上市や研究開発により、先進的な全自動臨床化学分析装置や半自動臨床化学分析装置の利用が引き続き促進され、世界の臨床化学分析装置市場が活性化するであろう。それぞれの革新的な化学分析装置には、ベンチトップ型とフロアスタンディング型の2種類があります。

市場促進要因:市場抑制要因

共同研究や買収の増加

新興経済諸国は、高額の投資、所得水準、インフラ整備を背景に、ヘルスケア分野の改善において急速な成長を遂げています。いくつかの国では、研究の活発化により臨床化学分析装置の需要が大きく伸びています。各国間での技術的進歩を伴う様々な提携、買収、製品の発売が市場成長を促進する重要な要因となっています。

2023年2月2日、医療機器のプロバイダーとして有名なシーメンス・ヘルティニアースと診断サービスのサプライヤーとして有名なユニラブによって、2億ユーロを超える複数年の取り決めが開始されました。ユニラボはシーメンス・ヘルティニアースの最先端技術に投資し、400台以上の科学分析装置を購入することで、ラボのインフラをさらにアップグレードし、顧客に比類ないサービスを提供します。

さらに、2021年2月3日、MedTest Holdings, Inc.は、HORIBA Instrumentsのアーバイン本社と株式会社堀場製作所の京都本社に買収されました。この買収により、堀場メディカルは、ポインテサイエンティフィック社とメドテスト社の優れた化学製品の革新的な技術を活用しながら、体外診断用医薬品市場の多分野にわたるニーズに応えることができるようになります。

さらに、新しい技術や様々なタイプの臨床化学分析装置が様々な研究目的で利用されるようになってきています。慢性疾患の増加と革新的な診断製品開発のための研究の増加は、臨床化学分析装置市場の成長を促進する主な要因です。

臨床化学分析装置にかかるコストの高さ

キットや消耗品のコスト、CPRTのコストは、臨床化学検査室で購入または利用する装置のタイプに影響を与える基準の一部であるが、最新の臨床化学検査室の装置のコストは高額です。

生化学分析装置には多額の初期投資が必要であり、最高級機種では$45,000もします。購入価格が高いため、病院のようなユーザーはレンタル契約で購入せざるを得ず、売上を下げています。

このレポートの詳細 - サンプル請求

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 共同研究や買収の増加
      • 技術的進歩と開発の高まり
    • 抑制要因
      • 臨床化学分析装置に関連する高コスト
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • SWOT分析
  • 特許分析
  • ロシア・ウクライナ戦争の影響分析
  • DMI意見

第6章 COVID-19分析

第7章 製品タイプ別

  • 全自動臨床化学分析装置
  • 半自動臨床化学分析装置

第8章 モダリティ別

  • 卓上型分析装置
  • 床置き型分析装置

第9章 用途別

  • 臨床診断
  • 医薬品検査
  • その他

第10章 エンドユーザー別

  • 病院
  • 学術・研究機関
  • 診断センター
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他の欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ

第12章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第13章 企業プロファイル

  • F. Hoffmann-La Roche Ltd
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • Beckman Coulter, Inc.
  • HORIBA Medical
  • Siemens Healthcare Private Limited
  • Hitachi High-Tech Corporation
  • Thermo Fisher Scientific Inc.
  • EKF Diagnostics Holdings plc
  • Abbott
  • Mindray Medical India Pvt. Ltd.
  • Randox Laboratories Ltd.

第14章 付録

目次
Product Code: BT7187

Overview

The global clinical chemistry analyzers market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. Clinical chemistry analyzers are crucial parts of automated medical laboratory equipment. These devices examine and characterize the fluid sample composition of biological samples like blood or urine. Advanced chemical or optical methods can be used to do this; however, more on that in a moment.

Government novel product launch and research, particularly in developing economies, will continue to drive utilization of advanced fully automatic clinical chemistry analyzers or semi-automatic clinical chemistry analyzers and boost the global clinical chemistry analyzers market. The respective innovative chemistry analyzers are in two modalities including bench-top and floor standing.

Market Dynamics: Drivers & Restraints

Growing collaborations and acquisitions

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high investments, income levels, and infrastructure development. Several countries have experienced substantial demand for clinical chemistry analyzers owing to the rising research. Various collaborations, acquisitions and product launches with technological advanecments among different countries will be a crucial factor driving the growth of the market.

On February 2, 2023, a multi-year arrangement with a value of more than €200 million was started by Siemens Healthineers, a renowned provider of medical equipment, and Unilabs, a renowned supplier of diagnostic services. Unilabs has invested in cutting-edge technology from Siemens Healthineers and will buy more than 400 scientific analyzers to further upgrade its laboratory infrastructure and provide its clients with unmatched service.

Additionally, on February 3, 2021, MedTest Holdings, Inc. has been purchased by the Irvine headquarters of HORIBA Instruments and the Kyoto, Japan headquarters of HORIBA, Ltd. Through this acquisition, HORIBA Medical will have the chance to serve the multidisciplinary needs of the IVD market while utilizing Pointe Scientific's and MedTest's superior Chemistry products' complimentary revolutionary technologies.

Furthermore, the rising utilization of novel technology and different types of clinical chemistry analyzers for the several research purposes. Rising chronic disorders and increasing research for innovative diagnostic product development will be a major factor driving the growth of the clinical chemistry analyzers market.

High cost associated with the clinical chemistry analyzers

Although the cost of kits or consumables, as well as the cost of the CPRT, are some of the criteria that may affect the type of instrument to be purchased or utilized in a clinical chemistry laboratory, the cost of the equipment in modern clinical chemistry laboratories is expensive.

Biochemistry analyzers involve a large initial investment; top-of-the-line models can cost up to $45,000. Because of their high acquisition prices, users like hospitals are forced to purchase them through rental agreements, which lowers sales.

For more details on this report - Request for Sample

Segment Analysis

The global clinical chemistry analyzers market is segmented based on product type, modality, application, end user and region.

Fully Automatic Clinical Chemistry Analyzers segment accounted for approximately 64% of market share

Fully automated chemical analyzers make it easier and more efficient to complete analytical tasks in various laboratory environments. Researchers can get evaluation results from these tools with exceptional precision. Get analysis reports in the shortest amount of time possible. A variety of diagnostic tasks are performed using fully automated chemical analyzers, including routine examination of albumin, glucose, creatinine, bilirubin, or inorganic phosphorus.

These are also employed in the execution of assays for the evaluation of lipids, therapeutic medications, illicit drugs, and more. Fully automated chemistry analyzers make it possible to do a variety of research tasks more quickly and deliver data in the shortest amount of time.

On June 8, 2023, the most recent offering from Mindray is the M1000 Chemistry with Immunoassay Integrated Solution, which combines an intelligent sample delivery module with two cutting-edge analyzers: the Chemiluminescence Immunoassay Analyzer CL-8000i and the state-of-the-art Chemistry Analyzer BS-2800M. Since its introduction, the solution has received a great deal of customer support and appreciation for its high degree of accuracy, effectiveness, and resilience, especially for the creative design and potent features of the experimental treatment system.

Geographical Penetration

North America accounted for around 34% of market share in 2022

Due to the rising need for clinical chemistry analyzers in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for clinical chemistry analyzers.

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different types of products, and increase in biopharmaceutical or biotechnology business establishment across the region are also contributing to the growth of clinical chemistry analyzers market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as fully automatic clinical chemistry analyzers. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global clinical chemistry analyzers market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for clinical chemistry analyzers in the U.S. United States have been proactive in executing several initiatives or researches, stimulating clinical chemistry analyzers demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global clinical chemistry analyzers market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020.

Major medical and biotechnology industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for clinical chemistry analyzers. Now several research studies have been initiated and companies have again started launching novel products with high efficiency. Overall, the impact of the pandemic on the global clinical chemistry analyzers market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for innovative products, like bench-top analyzers.

Key Developments

  • On July 25, 2023, the FDA has approved Beckman Coulter Diagnostics' new automated chemistry analyzer, DxC 500 AU Chemistry Analyzer. This decision expands the company's clinical chemistry offering and shows its continued commitment to product innovation in the in vitro diagnostics sector. The DxC 500 AU Chemistry Analyzer, one of several new Beckman Coulter products created to streamline laboratory operations and assist crucial clinical decisions, is intended for small-to-medium-sized laboratories.
  • On July 2o, 2023, the Atellica CI Analyzer for clinical chemistry testing or immunoassay, the newest addition to Siemens Healthineers' Atellica in vitro diagnostics portfolio, has acquired FDA clearance and is currently offered in many of the major markets across the world. The competitive benefits that the analyzer offers, such as enhanced turnaround time predictability, cutting-edge reporting features, and targeted safety and security measures, will be beneficial to labs operating at low to moderate testing volumes.

Competitive Landscape

The major global players in the market include: F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., HORIBA Medical, Siemens Healthcare Private Limited, Hitachi High-Tech Corporation, Thermo Fisher Scientific Inc., EKF Diagnostics Holdings plc, Abbott, Mindray Medical India Pvt. Ltd. And Randox Laboratories Ltd. Among others.

Why Purchase the Report?

  • To visualize the global clinical chemistry analyzers market segmentation based on product type, modality, application, end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of clinical chemistry analyzers market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The global clinical chemistry analyzers market report would provide approximately 69 tables, 66 figures and 186 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Modality
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing collaborations and acquisitions
      • 4.1.1.2. Rising technological advancements and developments
    • 4.1.2. Restraints
      • 4.1.2.1. High cost associated with the clinical chemistry analyzers
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. SWOT Analysis
  • 5.6. Patent Analysis
  • 5.7. Russia-Ukraine War Impact Analysis
  • 5.8. DMI Opinion

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Fully Automatic Clinical Chemistry Analyzers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Semi-Automatic Clinical Chemistry Analyzers

8. By Modality

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 8.1.2. Market Attractiveness Index, By Modality
  • 8.2. Bench-Top Analyzers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Floor-Standing Analyzers

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Clinical Diagnostics *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Drug Testing
  • 9.4. Others

10. By End User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.1.2. Market Attractiveness Index, By End User
  • 10.2. Hospitals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Academic or Research Laboratories
  • 10.4. Diagnostic Centers
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. UK
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. F. Hoffmann-La Roche Ltd*
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Beckman Coulter, Inc.
  • 13.3. HORIBA Medical
  • 13.4. Siemens Healthcare Private Limited
  • 13.5. Hitachi High-Tech Corporation
  • 13.6. Thermo Fisher Scientific Inc.
  • 13.7. EKF Diagnostics Holdings plc
  • 13.8. Abbott
  • 13.9. Mindray Medical India Pvt. Ltd.
  • 13.10. Randox Laboratories Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us